Mereo Biopharma Group Plc ADR (NASDAQ:MREO) shares, rose in value on Friday, November 22, with the stock price up by 1.09% to the previous day’s close as strong demand from buyers drove the stock to $3.72.
Actively observing the price movement in the last trading, the stock closed the session at $3.68, falling within a range of $3.645 and $3.81. Referring to stock’s 52-week performance, its high was $5.02, and the low was $1.86. On the whole, MREO has fluctuated by -14.48% over the past month.
With the market capitalization of Mereo Biopharma Group Plc ADR currently standing at about $575.60 million, investors are eagerly awaiting this quarter’s results, scheduled for in December.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 11.37M.
The stock’s technical analysis shows that the price of MREO currently trading nearly -6.17% and -10.45% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.37, while the 7-day volatility ratio is showing 7.80% which for the 30-day chart, stands at 5.55%. Furthermore, Mereo Biopharma Group Plc ADR (MREO)’s beta value is 0.97, and its average true range (ATR) is 0.23.
A comparison of Mereo Biopharma Group Plc ADR (MREO) with its peers suggests the former has fared considerably weaker in the market. MREO showed an intraday change of 1.09% in last session, and over the past year, it grew by 78.42%%.
Data on historical trading for Mereo Biopharma Group Plc ADR (NASDAQ:MREO) indicates that the trading volumes over the past 10 days have averaged 1.09 and over the past 3 months, they’ve averaged 764.59K. According to company’s latest data on outstanding shares, there are 154.73 million shares outstanding.
Nearly 8.23% of Mereo Biopharma Group Plc ADR’s shares belong to company insiders and institutional investors own 60.17% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.57 million shares as on 2024-10-31, resulting in a short ratio of 7.45. According to the data, the short interest in Mereo Biopharma Group Plc ADR (MREO) stood at 352.00 of shares outstanding as of 2024-10-31; the number of short shares registered in 2024-09-30 reached 4.88 million. The stock has risen by 61.04% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MREO stock heading into the next quarter.
